Compounders Research Compare

electroCore, Inc.(ECOR)

Medical - Devices · Rockaway, NJ

$10.16+0.02 (+0.25%)

Delayed quote: Oct 6, 2026, 1:44 PM EDT

About electroCore, Inc.

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Rockaway, NJ

83 employees

www.electrocore.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Joshua Lev

View full financials

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T17:46:18.564Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:46:18.564Z.

Quote observation: 2026-10-06T17:44:37.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 91,556,312
Total debt · period ending 2026-06-30: 9,563,000
Cash · period ending 2026-06-30: 8,501,000
TTM operating income · period ending 2026-06-30: -13,913,000

FMP input reference: 4f3bc52aaee10dc4864d073eee8720ed85d0d11e7a3d16422bde167dd05b99a5

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ECOR EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

ECOR Competitors' EV/EBIT Ratio

electroCore, Inc.

Current

Market Cap

$91.56M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ImmuCell Corporation

Market Cap

$88.48M

EV/EBIT Ratio

23.81x

TTM Avg

34.08x

3Y Avg

34.41x

5Y Avg

73.74x

PMV Pharmaceuticals, Inc.

Market Cap

$89.33M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Rallybio Corporation

Market Cap

$90.32M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Biomea Fusion, Inc.

Market Cap

$90.74M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Neumora Therapeutics, Inc. Common Stock

Market Cap

$88.45M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Equillium, Inc.

Market Cap

$91.05M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CareCloud, Inc.

Market Cap

$87.75M

EV/EBIT Ratio

13.65x

TTM Avg

11.03x

3Y Avg

8.69x

5Y Avg

166.50x

Park Dental Partners, Inc. Common Stock

Market Cap

$93.01M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Atara Biotherapeutics, Inc.

Market Cap

$85.78M

EV/EBIT Ratio

N/A

TTM Avg

10.94x

3Y Avg

10.94x

5Y Avg

10.94x

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
electroCore, Inc. (ECOR)	$91.56M	N/A	N/A	N/A	N/A
ImmuCell Corporation (ICCC)vs ›	$88.48M	23.81x	34.08x	34.41x	73.74x
PMV Pharmaceuticals, Inc. (PMVP)vs ›	$89.33M	N/A	N/A	N/A	N/A
Rallybio Corporation (RLYB)vs ›	$90.32M	N/A	N/A	N/A	N/A
Biomea Fusion, Inc. (BMEA)vs ›	$90.74M	N/A	N/A	N/A	N/A
Neumora Therapeutics, Inc. Common Stock (NMRA)vs ›	$88.45M	N/A	N/A	N/A	N/A
Equillium, Inc. (EQ)vs ›	$91.05M	N/A	N/A	N/A	N/A
CareCloud, Inc. (CCLD)vs ›	$87.75M	13.65x	11.03x	8.69x	166.50x
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$93.01M	N/A	N/A	N/A	N/A
Atara Biotherapeutics, Inc. (ATRA)vs ›	$85.78M	N/A	10.94x	10.94x	10.94x

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/EBITDA EV/Sales Operating Income All Metrics